Skip to main content
Clinical Trials/CTRI/2022/10/046885
CTRI/2022/10/046885
Not yet recruiting
Phase 2

A randomised controlled trial comparing once daily versus itch-based multiple daily application of clobetasol propionate 0.05% cream in lichen simplex chronicus

All India Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with clinical diagnosis of lichen simplex chronicus
  • 2\.More than 18 years of age
  • 3\.Patients with well circumscribed lesions of lichen simplex chronicus.

Exclusion Criteria

  • 1\.Use of systemic medications for treatment of other diseases which may act on the lesion
  • 2\.Lichen simplex chronicus due to underlying systemic or dermatological diseases
  • 3\.Lichen simplex chronicus superimposed on any other skin lesions
  • 4\.Lichen simplex chronicus of the anogenital region
  • 5\.Patients who do not consent for study or follow up
  • 6\.Pregnant and lactating females.

Outcomes

Primary Outcomes

Not specified

Similar Trials